Citigroup »

Rigel Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2024-09-30 $216k 13k 16.18
2024-06-30 $35k 4.3k 8.23

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Indl (XLI)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)

View all positions for Citigroup

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
BlackRock
Morgan Stanley
Invesco
Soleus Capital Management
Vanguard Group
Susquehanna International
Assenagon Asset Management
Acadian Asset Management
Geode Capital Management
State Street Corporation
Stonepine Capital Management
CM Management
Ing Investment Management

View all funds holding Rigel Pharmaceuticals